What is CareSignal?
CareSignal specializes in deviceless remote patient monitoring solutions designed to be accessible and cost-effective for a range of healthcare organizations, including self-insured commercial clients, payers, and Medicaid programs. Their platform automates patient engagement to proactively identify individuals at higher risk, thereby enabling timely interventions. The service has a proven track record of delivering substantial outcomes, such as reducing emergency department visits and improving the management of chronic diseases. CareSignal's focus on sustained patient engagement, coupled with their support services, ensures successful adoption and positive results for their partners.
How much funding has CareSignal raised?
CareSignal has raised a total of $765K across 1 funding round:
Debt
$765K
Debt (2015): $765K with participation from BioGenerator
Key Investors in CareSignal
BioGenerator
BioGenerator is an organization focused on supporting and investing in the life sciences sector, likely providing strategic capital and resources to companies like CareSignal that operate within healthcare innovation.
What's next for CareSignal?
The recent major strategic investment signals a pivotal growth phase for CareSignal, likely enabling the company to scale its operations, expand its market reach, and further develop its innovative remote patient monitoring technology. This capital infusion is expected to accelerate their mission of transforming value-based care by providing scalable and impactful solutions for patient engagement and risk stratification. Future developments may include broader integration with healthcare systems and enhanced data analytics capabilities to further demonstrate ROI for payers and providers.
See full CareSignal company page
